What is Lennox International Inc.'s earnings per share (EPS)?

Lennox International Inc. (LII) reported diluted earnings per share of $22.79 for fiscal year 2025. This represents a 0.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lennox International Inc. (LII) Financials

LII

Trailing 12 months to March 31, 2026

Revenue $5.3B -2.0% YoY

Net Income $793.5M -2.8% YoY

EPS (Diluted) $22.51 -0.8% YoY

Free Cash Flow $660.7M -14.5% YoY

Market Cap $12.5B as of Oct 6, 2026

Price / Sales 2.4x on $5.3B revenue, trailing 12 months to March 31, 2026

Price / Earnings 15.7x on $793.5M net income, trailing 12 months to March 31, 2026

Price / Book 10.3x on $1.2B equity, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Apr 29, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Apr 29, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LII SEC filings page.

Lennox International Inc. (LII) reported $5.3B in revenue over the twelve months to Mar 31, 2026, down 2.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LII FY2025 2026-10-03

Lennox has made profits more resilient through margin expansion, while 2025’s softer sales and heavier investment reduced cash conversion.

In FY2025, revenue fell 2.7% while operating margin reached 20.1%, indicating profit improvement was no longer volume-led and instead reflected better cost or product economics. Yet operating cash flow fell 19.9% and free cash flow fell 18.3% from FY2024 as investing outflows widened to $655.6M, so reported earnings remained stronger than near-term cash generation.

The balance sheet has been rebuilt: equity moved from -$269M in FY2021 to $1.2B in FY2025, changing leverage analysis from an accounting-deficit problem into a conventional capital-structure question. Debt-to-equity consequently shifted from -4.6x to 1.0x, making the ratio interpretable again.

The current ratio improved to 1.6x from 0.9x in FY2022, indicating that the earlier short-term funding squeeze had eased by FY2025. Inventory nevertheless rose to $1.2B from $853M while revenue declined, tying more capital to stock on hand and contributing to weaker cash conversion.

Financial Health Signals

Financial Health Score 63/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Lennox International Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Lennox International Inc. has an operating margin of 20.1%, meaning the company retains $20 of operating profit per $100 of revenue. This strong profitability earns a score of 84/100, reflecting efficient cost management and pricing power. This is up from 19.5% the prior year.

Growth

Lennox International Inc.'s revenue declined 2.7% year-over-year, from $5.3B to $5.2B. This contraction results in a growth score of 38/100.

Leverage

Lennox International Inc. has a moderate D/E ratio of 0.98. This balance of debt and equity financing earns a leverage score of 48/100.

Liquidity

Lennox International Inc.'s current ratio of 1.60 indicates adequate short-term liquidity, earning a score of 45/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Lennox International Inc. converts 12.3% of revenue into free cash flow ($638.8M). This strong cash generation earns a score of 72/100.

Returns

Lennox International Inc. earns a strong 69.3% return on equity (ROE), meaning it generates $69 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 92/100. This is down from 84.3% the prior year.

Altman Z-Score Safe

6.57

Lennox International Inc. scores 6.57, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Lennox International Inc. passes 5 of 9 financial strength tests. 2 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

0.94x

For every $1 of reported earnings, Lennox International Inc. generates $0.94 in operating cash flow ($757.6M OCF vs $805.8M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage Safe

25.46x

Lennox International Inc. earns $25.46 in operating income for every $1 of interest expense ($1.0B vs $40.9M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY+5.8%

QoQ-5.0%

5Y CAGR+4.1%

10Y CAGR+4.7%

Lennox International Inc. generated $1.1B in revenue in Q1 2026. This represents an increase of 5.8% from the same quarter a year earlier. Against the prior quarter it is down 5.0%.

EBITDA

$192.7M

YoY-0.5%

QoQ-15.8%

Lennox International Inc.'s EBITDA was $192.7M in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 15.8%.

Net Income

$117.2M

YoY-9.6%

QoQ-17.8%

Lennox International Inc. reported $117.2M in net income in Q1 2026. This represents a decrease of 9.6% from the same quarter a year earlier. Against the prior quarter it is down 17.8%.

EPS (Diluted)

$3.35

YoY-7.7%

QoQ-17.7%

5Y CAGR+8.8%

10Y CAGR+19.6%

Lennox International Inc. earned $3.35 per diluted share (EPS) in Q1 2026. This represents a decrease of 7.7% from the same quarter a year earlier. Against the prior quarter it is down 17.7%.

Cash & Balance Sheet

Free Cash Flow

-$39.4M

YoY+35.7%

QoQ-110.5%

Lennox International Inc. recorded an outflow of $39.4M in free cash flow in Q1 2026, representing a cash shortfall after capex. This represents an increase of 35.7% from the same quarter a year earlier. Against the prior quarter it is down 110.5%.

Cash & Debt

$48.2M

YoY-77.8%

QoQ+40.9%

5Y CAGR+6.3%

10Y CAGR+1.7%

Lennox International Inc. held $48.2M in cash against $1.1B in long-term debt as of Q1 2026.

Shares Outstanding

35M

YoY-1.9%

QoQ0.0%

5Y CAGR-1.6%

10Y CAGR-2.2%

Lennox International Inc. had 35M shares outstanding in Q1 2026. This represents a decrease of 1.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

30.9%

YoY-0.8pp

QoQ-1.6pp

Lennox International Inc.'s gross margin was 30.9% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.6 percentage points.

Operating Margin

14.4%

YoY-1.3pp

QoQ-2.0pp

Lennox International Inc.'s operating margin was 14.4% in Q1 2026, reflecting core business profitability. This is down 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.0 percentage points.

Net Margin

10.3%

YoY-1.8pp

QoQ-1.6pp

Lennox International Inc.'s net profit margin was 10.3% in Q1 2026, showing the share of revenue converted to profit. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.6 percentage points.

Return on Equity

9.7%

YoY-3.7pp

QoQ-2.6pp

Lennox International Inc.'s ROE was 9.7% in Q1 2026, measuring profit generated per dollar of shareholder equity. This is down 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.6 percentage points.

Capital Allocation

Share Buybacks

$19.5M

YoY-77.1%

QoQ-87.0%

5Y CAGR-37.2%

10Y CAGR-20.8%

Lennox International Inc. spent $19.5M on share buybacks in Q1 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 77.1% from the same quarter a year earlier. Against the prior quarter it is down 87.0%.

Capital Expenditures

$55.5M

YoY+117.6%

QoQ+90.1%

5Y CAGR+17.6%

10Y CAGR+8.8%

Lennox International Inc. invested $55.5M in capex in Q1 2026, funding long-term assets and infrastructure. This represents an increase of 117.6% from the same quarter a year earlier. Against the prior quarter it is up 90.1%.

R&D Spending

Not reported for Q1 2026.

LII Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LII quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$5.3B	$5.2B-2.7%	$5.3B+7.2%	$5.0B+5.6%	$4.7B+12.5%	$4.2B+15.4%	$3.6B-4.5%	$3.8B-2.0%	$3.9B+1.2%	$3.8B+5.4%	$3.6B+5.0%	$3.5B+3.0%	$3.4B+5.3%	$3.2B+8.5%	$2.9B+3.8%	$2.8B
Cost of Revenue	$3.5B	$3.5B-2.9%	$3.6B+3.8%	$3.4B0.0%	$3.4B+14.2%	$3.0B+15.9%	$2.6B-4.9%	$2.7B-1.6%	$2.8B+2.1%	$2.7B+5.8%	$2.6B+1.8%	$2.5B+2.3%	$2.5B+5.4%	$2.3B+5.0%	$2.2B+2.6%	$2.2B
Gross Profit	$1.7B	$1.7B-2.4%	$1.8B+14.7%	$1.5B+20.6%	$1.3B+8.1%	$1.2B+14.3%	$1.0B-3.7%	$1.1B-2.8%	$1.1B-1.2%	$1.1B+4.5%	$1.1B+13.6%	$947.4M+4.9%	$903.3M+4.9%	$861.2M+19.2%	$722.3M+7.8%	$669.9M
R&D Expenses	N/A	$103.4M+10.5%	$93.6M-0.4%	$94.0M+17.1%	$80.3M+5.5%	$76.1M+13.9%	$66.8M-4.4%	$69.9M-3.2%	$72.2M-1.9%	$73.6M+13.9%	$64.6M+3.7%	$62.3M+2.6%	$60.7M+13.0%	$53.7M+5.9%	$50.7M+0.8%	$50.3M
SG&A Expenses	N/A	$681.4M-6.7%	$730.6M+3.6%	$705.5M+12.5%	$627.2M+4.7%	$598.9M+7.7%	$555.9M-5.1%	$585.9M-3.7%	$608.2M-4.6%	$637.7M+2.7%	$621.0M+7.0%	$580.5M+1.2%	$573.7M+0.6%	$570.1M+12.4%	$507.0M+6.3%	$476.9M
Operating Income	$1.0B	$1.0B+0.1%	$1.0B+31.4%	$791.5M+20.6%	$656.2M+11.2%	$590.3M+23.4%	$478.5M-27.2%	$656.9M+28.8%	$509.9M+3.1%	$494.5M+15.2%	$429.4M+40.6%	$305.4M-8.8%	$334.7M+15.8%	$289.0M+31.9%	$219.1M+18.8%	$184.4M
EBITDA	N/A	$1.2B+1.6%	$1.1B+29.4%	$877.5M+19.5%	$734.1M+10.8%	$662.7M+20.3%	$551.1M-24.3%	$728.0M+26.4%	$575.9M+3.0%	$559.1M+14.7%	$487.5M+32.4%	$368.2M-6.9%	$395.5M+13.7%	$347.9M+26.7%	$274.5M+13.9%	$241.0M
Interest Expense	N/A	$40.9M+5.7%	$38.7M-25.1%	$51.7M+33.6%	$38.7M+54.8%	$25.0M-11.7%	$28.3M-40.4%	$47.5M+24.0%	$38.3M+25.2%	$30.6M+13.3%	$27.0M+14.4%	$23.6M+37.2%	$17.2M+18.6%	$14.5M-15.2%	$17.1M+1.8%	$16.8M
Income Tax	$189.5M	$191.0M+1.4%	$188.3M+27.5%	$147.7M+24.4%	$118.7M+23.5%	$96.1M+9.1%	$88.1M-11.1%	$99.1M-7.9%	$107.6M-31.4%	$156.9M+26.4%	$124.1M+30.1%	$95.4M-12.9%	$109.5M+16.0%	$94.4M+41.5%	$66.7M+19.5%	$55.8M
Net Income	$793.5M	$805.8M-0.7%	$811.1M+37.2%	$591.2M+18.9%	$497.1M+7.1%	$464.0M+30.2%	$356.3M-12.8%	$408.7M+13.8%	$359.0M+17.4%	$305.7M+10.0%	$277.8M+48.9%	$186.6M-9.3%	$205.8M+19.8%	$171.8M+90.9%	$90.0M+1.9%	$88.3M
EPS (Basic)	N/A	$22.89+0.5%	$22.78+36.8%	$16.65+19.6%	$13.92+11.6%	$12.47+34.1%	$9.30-11.3%	$10.49+18.7%	$8.84+21.9%	$7.25+13.5%	$6.39+53.6%	$4.16-3.3%	$4.30+24.6%	$3.45+94.9%	$1.77+5.4%	$1.68
EPS (Diluted)	$22.51	$22.79+0.6%	$22.66+36.7%	$16.58+19.5%	$13.88+12.0%	$12.39+34.1%	$9.24-11.0%	$10.38+18.8%	$8.74+22.4%	$7.14+13.0%	$6.32+54.5%	$4.09-3.3%	$4.23+24.8%	$3.39+93.7%	$1.75+6.1%	$1.65
Diluted Shares (Avg)	N/A	35M-1.1%	36M+0.3%	36M-0.3%	36M-4.5%	38M-2.8%	39M-2.0%	39M-4.1%	41M-4.0%	43M-2.7%	44M-3.5%	46M-6.2%	49M-4.0%	51M-1.6%	51M-3.7%	53M

Metric	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$1.1B+5.8%	$1.2B-11.2%	$1.4B-4.8%	$1.5B+3.4%	$1.1B+2.4%	$1.3B+16.5%	$1.5B+9.6%	$1.5B+2.8%
Cost of Revenue	$783.8M+7.1%	$805.7M-8.9%	$939.6M-6.9%	$983.4M+2.1%	$731.7M+3.5%	$884.1M+10.7%	$1.0B+7.7%	$962.9M+1.0%
Gross Profit	$351.3M+3.1%	$389.3M-15.5%	$487.2M-0.2%	$517.5M+6.0%	$340.9M+0.3%	$460.9M+29.4%	$488.4M+14.0%	$488.2M+6.6%
SG&A Expenses	$185.2M+8.1%	N/A	$161.6M-12.4%	$173.3M+2.8%	$171.3M+0.4%	$207.0M+16.4%	$184.4M+3.1%	$168.5M-7.1%
Operating Income	$163.5M-2.7%	$195.8M-21.7%	$328.8M+8.4%	$349.0M+9.0%	$168.0M+0.7%	$250.2M+34.2%	$303.3M+62.4%	$320.1M+14.8%
EBITDA	$192.7M-0.5%	$228.9M-17.0%	$355.8M+9.9%	$375.8M+8.8%	$193.6M+1.5%	$275.7M+31.0%	$323.7M+55.4%	$345.3M+15.2%
Interest Expense	$15.2M+145.2%	N/A	$10.5M+18.0%	$8.3M-33.6%	$6.2M-47.5%	$5.5M-51.3%	$8.9M-20.5%	$12.5M-16.7%
Income Tax	$29.7M-4.8%	$36.2M-14.6%	$57.5M+4.7%	$66.1M+8.2%	$31.2M+4.3%	$42.4M+44.7%	$54.9M+22.5%	$61.1M+31.4%
Net Income	$117.2M-9.6%	$142.5M-29.4%	$259.9M+8.7%	$273.9M+11.4%	$129.6M+4.3%	$201.9M+38.7%	$239.0M+83.3%	$245.9M+13.2%
EPS (Basic)	$3.37-7.7%	$4.08-26.6%	$7.41+10.4%	$7.75+12.2%	$3.65+4.6%	$5.56+36.9%	$6.71+82.8%	$6.91+12.9%
EPS (Diluted)	$3.35-7.7%	$4.07-26.3%	$7.38+10.5%	$7.71+12.2%	$3.63+4.6%	$5.52+37.0%	$6.68+83.0%	$6.87+12.6%
Diluted Shares (Avg)	35M-2.0%	N/A	35M-1.7%	36M-0.8%	36M-0.3%	N/A	36M+0.3%	36M+0.6%

Not reported in any period shown, so not listed: R&D Expenses.

LII Balance Sheet

LII quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$4.1B+12.8%	$3.6B+23.1%	$2.9B+14.5%	$2.6B+18.2%	$2.2B+6.9%	$2.0B-0.1%	$2.0B+12.0%	$1.8B-3.9%	$1.9B+7.5%	$1.8B+4.9%	$1.7B-4.9%	$1.8B+8.5%	$1.6B-3.9%	$1.7B-0.8%	$1.7B
Current Assets	$1.9B-6.3%	$2.0B+28.9%	$1.6B+5.3%	$1.5B+27.3%	$1.2B+8.1%	$1.1B-3.0%	$1.1B+2.9%	$1.1B-4.2%	$1.1B+13.1%	$1.0B+7.2%	$938.2M-4.4%	$981.5M+8.8%	$902.4M-8.6%	$987.1M-2.5%	$1.0B
Cash & Equivalents	$34.2M-91.8%	$415.1M+583.9%	$60.7M+15.4%	$52.6M+69.7%	$31.0M-75.0%	$123.9M+232.2%	$37.3M-19.4%	$46.3M-32.1%	$68.2M+35.9%	$50.2M+29.0%	$38.9M+3.7%	$37.5M-1.3%	$38.0M-26.6%	$51.8M+15.1%	$45.0M
Short-Term Investments	$500K-93.1%	$7.2M-14.3%	$8.4M-1.2%	$8.5M+54.5%	$5.5M+7.8%	$5.1M+75.9%	$2.9M	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.2B+35.1%	$853.0M+1.3%	$841.8M+11.8%	$753.0M+47.4%	$510.9M+16.3%	$439.4M-19.2%	$544.1M+6.7%	$509.8M+5.3%	$484.2M+15.7%	$418.5M-0.1%	$418.8M-9.6%	$463.3M+22.3%	$378.8M+1.1%	$374.8M+17.9%	$317.9M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$497.2M+126.0%	$220.0M-0.9%	$222.1M+19.2%	$186.3M-0.2%	$186.6M-0.2%	$186.9M+0.2%	$186.5M-0.1%	$186.6M-6.9%	$200.5M+2.8%	$195.1M0.0%	$195.1M-6.8%	$209.4M-3.4%	$216.8M-3.1%	$223.8M+0.3%	$223.2M
Total Liabilities	$2.9B+9.8%	$2.7B+4.3%	$2.5B-8.0%	$2.8B+13.5%	$2.4B+19.1%	$2.0B-7.1%	$2.2B+12.1%	$2.0B+6.8%	$1.8B+6.9%	$1.7B+9.3%	$1.6B-10.2%	$1.8B+53.8%	$1.1B-4.4%	$1.2B-3.6%	$1.2B
Current Liabilities	$1.2B-9.3%	$1.3B+29.4%	$1.0B-36.4%	$1.6B+92.9%	$827.1M+17.9%	$701.3M-30.1%	$1.0B-0.6%	$1.0B+54.1%	$654.5M-26.3%	$888.6M+7.9%	$823.8M-0.4%	$827.3M+15.9%	$714.0M+19.0%	$600.0M+4.0%	$577.1M
Non-Current Liabilities	$1.7B+28.4%	$1.3B-12.3%	$1.5B+30.5%	$1.2B-27.2%	$1.6B+19.7%	$1.3B+12.1%	$1.2B+25.5%	$958.3M-19.3%	$1.2B+42.4%	$833.7M+10.9%	$752.0M-19.0%	$928.0M+117.3%	$427.0M-28.1%	$593.6M-10.2%	$660.8M
Long-Term Debt	$1.1B+37.3%	$833.1M-27.1%	$1.1B+40.4%	$814.2M-33.6%	$1.2B+26.4%	$970.7M+14.3%	$849.3M+14.7%	$740.5M-23.7%	$970.5M+57.6%	$615.7M+21.7%	$506.0M-25.0%	$675.0M+189.5%	$233.2M-33.6%	$351.0M-23.6%	$459.6M
Total Equity	$1.2B+20.9%	$962.1M+144.8%	$393.0M+293.5%	-$203.1M+24.5%	-$269.0M-1473.1%	-$17.1M+90.0%	-$170.2M-13.8%	-$149.6M-398.6%	$50.1M+31.8%	$38.0M-62.6%	$101.6M+1028.9%	$9.0M-98.1%	$485.7M-2.5%	$498.3M+6.2%	$469.0M
Retained Earnings	$4.9B+14.7%	$4.3B+18.0%	$3.6B+17.7%	$3.1B+12.9%	$2.7B+14.0%	$2.4B+11.0%	$2.1B+15.8%	$1.9B+17.7%	$1.6B+16.5%	$1.4B+18.0%	$1.1B+12.2%	$1.0B+17.4%	$870.5M+16.9%	$744.4M+7.4%	$692.9M

Metric	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$4.3B+24.2%	$4.1B+12.8%	$3.5B+6.4%	$3.7B+13.4%	$3.5B+15.7%	$3.6B+23.1%	$3.3B+14.6%	$3.2B+8.1%
Current Assets	$2.0B+9.5%	$1.9B-6.3%	$1.9B+3.7%	$2.0B+13.5%	$1.9B+18.6%	$2.0B+28.9%	$1.8B+5.1%	$1.8B-3.4%
Cash & Equivalents	$48.2M-77.8%	$34.2M-91.8%	$52.9M-78.2%	$49.2M+3.4%	$217.2M+375.3%	$415.1M+583.9%	$243.1M+84.2%	$47.6M-7.4%
Short-Term Investments	$2.0M-64.9%	$500K-93.1%	$6.3M-50.0%	$5.9M-42.2%	$5.7M-52.1%	$7.2M-14.3%	$12.6M+31.3%	$10.2M+41.7%
Inventory	$1.2B+34.1%	$1.2B+35.1%	$991.5M+43.9%	$1.0B+29.1%	$902.3M+9.6%	$853.0M+1.3%	$689.2M-7.8%	$776.3M-9.3%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$503.7M+129.0%	$497.2M+126.0%	$220.0M0.0%	$220.0M0.0%	$220.0M0.0%	$220.0M-0.9%	$219.9M+21.0%	$219.9M+18.0%
Total Liabilities	$3.1B+18.3%	$2.9B+9.8%	$2.5B-4.1%	$2.8B+4.1%	$2.6B-0.5%	$2.7B+4.3%	$2.6B-6.3%	$2.6B-9.4%
Current Liabilities	$1.3B-0.2%	$1.2B-9.3%	$1.1B-14.1%	$1.4B+28.4%	$1.3B+18.0%	$1.3B+29.4%	$1.3B+4.9%	$1.1B-36.6%
Non-Current Liabilities	$1.8B+36.5%	$1.7B+28.4%	$1.3B+6.6%	$1.3B-13.4%	$1.3B-13.9%	$1.3B-12.3%	$1.2B-15.7%	$1.5B+30.9%
Long-Term Debt	$1.1B+37.1%	$1.1B+37.3%	$838.2M+1.3%	$835.7M-25.8%	$834.2M-27.7%	$833.1M-27.1%	$827.6M-26.2%	$1.1B+37.8%
Total Equity	$1.2B+24.7%	$1.2B+20.9%	$1.1B+41.9%	$900.5M+56.0%	$973.7M+164.0%	$962.1M+144.8%	$754.0M+372.7%	$577.4M+822.4%
Retained Earnings	$5.0B+17.3%	$4.9B+14.7%	$4.7B+16.7%	$4.5B+17.5%	$4.2B+17.8%	$4.3B+18.0%	$4.0B+17.5%	$3.8B+14.7%

Not reported in any period shown, so not listed: Accounts Receivable.

LII Cash Flow Statement

LII quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$809.5M	$757.6M-19.9%	$945.7M+28.5%	$736.2M+143.5%	$302.3M-41.4%	$515.5M-15.8%	$612.4M+54.6%	$396.1M-20.1%	$495.5M+52.4%	$325.1M-13.1%	$373.9M+5.7%	$353.6M+91.3%	$184.8M-12.1%	$210.3M-5.0%	$221.4M+190.6%	$76.2M
Depreciation & Amortization	N/A	$112.5M+18.3%	$95.1M+10.6%	$86.0M+10.4%	$77.9M+7.6%	$72.4M-0.3%	$72.6M+2.1%	$71.1M+7.7%	$66.0M+2.2%	$64.6M+11.2%	$58.1M-7.5%	$62.8M+3.3%	$60.8M+3.2%	$58.9M+6.3%	$55.4M-2.1%	$56.6M
Stock-Based Compensation	N/A	$29.1M+2.1%	$28.5M-5.3%	$30.1M+38.1%	$21.8M-10.3%	$24.3M0.0%	$24.3M+14.1%	$21.3M-19.0%	$26.3M+5.6%	$24.9M-21.5%	$31.7M+19.2%	$26.6M+14.2%	$23.3M-20.5%	$29.3M+92.8%	$15.2M+10.9%	$13.7M
Capital Expenditures	$148.8M	$118.8M-27.4%	$163.6M-34.6%	$250.2M+147.5%	$101.1M-5.3%	$106.8M+36.1%	$78.5M-25.7%	$105.6M+10.9%	$95.2M-3.2%	$98.3M+16.6%	$84.3M+20.6%	$69.9M-20.9%	$88.4M+12.9%	$78.3M+56.0%	$50.2M+21.3%	$41.4M
Free Cash Flow	$660.7M	$638.8M-18.3%	$782.1M+60.9%	$486.0M+141.6%	$201.2M-50.8%	$408.7M-23.5%	$533.9M+83.8%	$290.5M-27.4%	$400.3M+76.5%	$226.8M-21.7%	$289.6M+2.1%	$283.7M+194.3%	$96.4M-27.0%	$132.0M-22.9%	$171.2M+392.0%	$34.8M
Investing Cash Flow	-$688.7M	-$655.6M-275.9%	-$174.4M+45.4%	-$319.7M-210.4%	-$103.0M+3.2%	-$106.4M-33.5%	-$79.7M-601.3%	$15.9M-47.9%	$30.5M+131.1%	-$98.1M-16.6%	-$84.1M-20.5%	-$69.8M+20.0%	-$87.3M-29.7%	-$67.3M-66.6%	-$40.4M+77.3%	-$177.8M
Financing Cash Flow	-$267.4M	-$465.7M-11.3%	-$418.6M-3.1%	-$406.2M-133.3%	-$174.1M+65.1%	-$498.7M-12.9%	-$441.8M-4.3%	-$423.4M+21.3%	-$537.8M-146.4%	-$218.3M+20.5%	-$274.6M-1.3%	-$271.1M-202.9%	-$89.5M+40.4%	-$150.2M+16.6%	-$180.1M-1413.4%	-$11.9M
Dividends Paid	$90.8M	$173.0M+7.9%	$160.3M+4.5%	$153.4M+8.0%	$142.0M+12.3%	$126.5M+7.1%	$118.1M+6.9%	$110.5M+17.7%	$93.9M+17.8%	$79.7M+15.5%	$69.0M+16.4%	$59.3M+12.7%	$52.6M+54.7%	$34.0M-28.6%	$47.6M+30.4%	$36.5M
Share Buybacks	$416.6M	$482.3M+799.8%	$53.6M	$0-100.0%	$300.0M-50.0%	$600.0M+500.0%	$100.0M-75.0%	$400.0M-11.2%	$450.2M+80.1%	$250.0M-16.7%	$300.0M	$0-100.0%	$550.3M+340.2%	$125.0M+149.5%	$50.1M-58.1%	$119.7M

Metric	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	$16.1M+145.0%	$405.9M+22.1%	$300.7M-33.5%	$86.8M-52.8%	-$35.8M-57.0%	$332.4M+8.5%	$452.1M+44.3%	$184.0M-5.9%
Depreciation & Amortization	$29.2M+14.1%	$33.1M+29.8%	$27.0M+32.4%	$26.8M+6.3%	$25.6M+6.7%	$25.5M+6.3%	$20.4M-5.1%	$25.2M+20.6%
Stock-Based Compensation	$6.3M0.0%	N/A	$6.3M-7.4%	$8.2M+28.1%	$6.3M-4.5%	N/A	$6.8M-29.9%	$6.4M-16.9%
Capital Expenditures	$55.5M+117.6%	$29.2M-51.5%	$35.6M-13.6%	$28.5M-12.8%	$25.5M-13.6%	$60.2M-51.9%	$41.2M+3.8%	$32.7M-34.5%
Free Cash Flow	-$39.4M+35.7%	$376.7M+38.4%	$265.1M-35.5%	$58.3M-61.5%	-$61.3M-17.2%	$272.2M+50.3%	$410.9M+50.2%	$151.3M+3.9%
Investing Cash Flow	-$56.6M-140.9%	-$568.0M-756.7%	-$36.0M+29.3%	-$28.1M-6.0%	-$23.5M+23.5%	-$66.3M+66.0%	-$50.9M-20.6%	-$26.5M+45.5%
Financing Cash Flow	$57.1M+140.4%	$161.7M+277.3%	-$259.2M-24.0%	-$227.0M-41.3%	-$141.2M-433.0%	-$91.2M+52.2%	-$209.1M-15.0%	-$160.7M-19.1%
Dividends Paid	$45.2M+10.5%	$45.6M+11.2%	$1+13.0%	$1+18.2%	$40.9M+4.6%	$41.0M	$1+4.5%	$10.0%
Share Buybacks	$19.5M-77.1%	$150.5M+269.8%	$37.0M+186.8%	$209.6M	$85.2M	$40.7M	$12.9M	$0

LII Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LII quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	33.4%+0.1pp	33.3%+2.2pp	31.1%+3.9pp	27.2%-1.1pp	28.3%-0.3pp	28.6%+0.3pp	28.4%-0.3pp	28.6%-0.7pp	29.3%-0.2pp	29.6%+2.2pp	27.3%+0.5pp	26.8%-0.1pp	26.9%+2.4pp	24.5%+0.9pp	23.6%
Operating Margin	20.1%+0.6pp	19.5%+3.6pp	15.9%+2.0pp	13.9%-0.2pp	14.1%+0.9pp	13.2%-4.1pp	17.3%+4.1pp	13.1%+0.3pp	12.9%+1.1pp	11.8%+3.0pp	8.8%-1.1pp	9.9%+0.9pp	9.0%+1.6pp	7.4%+0.9pp	6.5%
Net Margin	15.5%+0.3pp	15.2%+3.3pp	11.9%+1.3pp	10.5%-0.5pp	11.1%+1.3pp	9.8%-0.9pp	10.7%+1.5pp	9.2%+1.3pp	8.0%+0.3pp	7.6%+2.3pp	5.4%-0.7pp	6.1%+0.7pp	5.4%+2.3pp	3.0%-0.1pp	3.1%
Return on Equity	69.3%-15.0pp	84.3%-66.1pp	150.4%	N/A	N/A	N/A	N/A	N/A	610.2%-120.9pp	731.1%+547.4pp	183.7%-2103.0pp	2286.7%+2251.3pp	35.4%+17.3pp	18.1%-0.8pp	18.8%
Return on Assets	19.7%-2.7pp	22.4%+2.3pp	20.1%+0.7pp	19.4%-2.0pp	21.4%+3.8pp	17.5%-2.5pp	20.1%+0.3pp	19.8%+3.6pp	16.2%+0.4pp	15.8%+4.7pp	11.1%-0.5pp	11.7%+1.1pp	10.6%+5.2pp	5.3%+0.1pp	5.2%
Current Ratio	1.600.0x	1.550.0x	1.55+0.6x	0.94-0.5x	1.42-0.1x	1.55+0.4x	1.120.0x	1.08-0.7x	1.74+0.6x	1.130.0x	1.140.0x	1.19-0.1x	1.26-0.4x	1.65-0.1x	1.75
Debt-to-Equity	0.98+0.1x	0.87-2.0x	2.91	N/A	N/A	N/A	N/A	N/A	19.37+3.2x	16.20+11.2x	4.98-70.0x	75.00+74.5x	0.48-0.2x	0.70-0.3x	0.98
Asset Turnover	1.27-0.2x	1.48-0.2x	1.69-0.1x	1.84-0.1x	1.93+0.1x	1.79-0.1x	1.87-0.3x	2.14+0.1x	2.030.0x	2.070.0x	2.07+0.2x	1.91-0.1x	1.97+0.2x	1.74+0.1x	1.67
FCF Margin	12.3%-2.3pp	14.6%+4.9pp	9.8%+5.5pp	4.3%-5.5pp	9.7%-5.0pp	14.7%+7.1pp	7.6%-2.7pp	10.3%+4.4pp	5.9%-2.0pp	8.0%-0.2pp	8.2%+5.3pp	2.9%-1.3pp	4.1%-1.7pp	5.8%+4.6pp	1.2%

Metric	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-K	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	30.9%-0.8pp	32.6%-1.7pp	34.2%+1.6pp	34.5%+0.8pp	31.8%-0.7pp	34.3%+3.4pp	32.6%+1.2pp	33.6%+1.2pp
Operating Margin	14.4%-1.3pp	16.4%-2.2pp	23.0%+2.8pp	23.3%+1.2pp	15.7%-0.3pp	18.6%+2.5pp	20.3%+6.6pp	22.1%+2.3pp
Net Margin	10.3%-1.8pp	11.9%-3.1pp	18.2%+2.3pp	18.3%+1.3pp	12.1%+0.2pp	15.0%+2.4pp	16.0%+6.4pp	17.0%+1.6pp
Return on Equity	9.7%-3.7pp	12.3%-8.7pp	24.3%-7.4pp	30.4%-12.2pp	13.3%-20.4pp	21.0%-16.1pp	31.7%-50.1pp	42.6%-304.4pp
Return on Assets	2.7%-1.0pp	3.5%-2.1pp	7.4%+0.2pp	7.5%-0.1pp	3.8%-0.4pp	5.6%+0.6pp	7.2%+2.7pp	7.6%+0.3pp
Current Ratio	1.57+0.1x	1.600.0x	1.68+0.3x	1.41-0.2x	1.430.0x	1.550.0x	1.390.0x	1.60+0.5x
Debt-to-Equity	0.94+0.1x	0.98+0.1x	0.78-0.3x	0.93-1.0x	0.86-2.3x	0.87-2.0x	1.10-5.9x	1.95-11.1x
Asset Turnover	0.260.0x	0.29-0.1x	0.400.0x	0.410.0x	0.310.0x	0.370.0x	0.450.0x	0.450.0x
FCF Margin	-3.5%+2.3pp	31.5%+11.3pp	18.6%-8.8pp	3.9%-6.6pp	-5.7%-0.7pp	20.2%+4.6pp	27.4%+7.4pp	10.4%+0.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Lennox International Inc. LII	FY2025	$5.2B	$805.8M	15.5%	$12.5B	63/100
Carlisle Companies, Inc. CSL	FY2025	$5.0B	$740.7M	14.8%	$13.1B	70/100
Builders FirstSource, Inc. BLDR	FY2025	$15.2B	$435.2M	2.9%	$6.1B	47/100
Masco Corporation MAS	FY2025	$7.6B	$810.0M	10.7%	$13.5B	61/100
Owens Corning OC	FY2025	$10.1B	-$522.0M	-5.2%	$9.4B	52/100
ADVANCED DRAINAGE SYSTEMS, INC. WMS	FY2026	$3.1B	$429.0M	14.1%	$9.6B	66/100

Where Lennox International Inc. Ranks

Frequently Asked Questions

What is Lennox International Inc.'s annual revenue?

Lennox International Inc. (LII) reported $5.2B in total revenue for fiscal year 2025. This represents a -2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lennox International Inc.'s revenue growing?

Lennox International Inc. (LII) revenue declined by 2.7% year-over-year, from $5.3B to $5.2B in fiscal year 2025.

Is Lennox International Inc. profitable?

Yes, Lennox International Inc. (LII) reported a net income of $805.8M in fiscal year 2025, with a net profit margin of 15.5%.

What is Lennox International Inc.'s EBITDA?

Lennox International Inc. (LII) had EBITDA of $1.2B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Lennox International Inc. have?

As of fiscal year 2025, Lennox International Inc. (LII) had $34.2M in cash and equivalents against $1.1B in long-term debt.

What is Lennox International Inc.'s gross margin?

Lennox International Inc. (LII) had a gross margin of 33.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lennox International Inc.'s operating margin?

Lennox International Inc. (LII) had an operating margin of 20.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Lennox International Inc.'s net profit margin?

Lennox International Inc. (LII) had a net profit margin of 15.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Lennox International Inc. pay dividends?

Yes, Lennox International Inc. (LII) paid $5.05 per share in dividends during fiscal year 2025.

What is Lennox International Inc.'s return on equity (ROE)?

Lennox International Inc. (LII) has a return on equity of 69.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lennox International Inc.'s free cash flow?

Lennox International Inc. (LII) generated $638.8M in free cash flow during fiscal year 2025. This represents a -18.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lennox International Inc.'s operating cash flow?

Lennox International Inc. (LII) generated $757.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Lennox International Inc.'s total assets?

Lennox International Inc. (LII) had $4.1B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lennox International Inc.'s capital expenditures?

Lennox International Inc. (LII) invested $118.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Lennox International Inc. spend on research and development?

Lennox International Inc. (LII) invested $103.4M in research and development during fiscal year 2025.

Does Lennox International Inc. buy back shares?

Yes, Lennox International Inc. (LII) spent $482.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Lennox International Inc. have outstanding?

Lennox International Inc. (LII) had 35M shares outstanding as of fiscal year 2025.

What is Lennox International Inc.'s current ratio?

Lennox International Inc. (LII) had a current ratio of 1.60 as of fiscal year 2025, which is generally considered healthy.

What is Lennox International Inc.'s debt-to-equity ratio?

Lennox International Inc. (LII) had a debt-to-equity ratio of 0.98 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lennox International Inc.'s return on assets (ROA)?

Lennox International Inc. (LII) had a return on assets of 19.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lennox International Inc.'s P/E ratio?

Lennox International Inc. (LII) trades at 15.7x earnings, its market capitalization divided by net income of $793.5M net income, trailing 12 months to March 31, 2026. The market capitalization is $12.5B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lennox International Inc.'s price-to-sales ratio?

Lennox International Inc. (LII) trades at 2.4x sales, its market capitalization divided by revenue of $5.3B revenue, trailing 12 months to March 31, 2026. The market capitalization is $12.5B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Lennox International Inc.'s Altman Z-Score?

Lennox International Inc. (LII) has an Altman Z-Score of 6.57, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Lennox International Inc.'s Piotroski F-Score?

Lennox International Inc. (LII) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lennox International Inc.'s earnings high quality?

Lennox International Inc. (LII) has an earnings quality ratio of 0.94x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Lennox International Inc. cover its interest payments?

Lennox International Inc. (LII) has an interest coverage ratio of 25.46x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Lennox International Inc.?

Lennox International Inc. (LII) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.